1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cold Agglutinin Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Corticosteroids 1.2.3 Alkylating Agents 1.2.4 Purine Nucleoside Analogs 1.2.5 Biologics 1.2.6 Others 1.3 Market by Application 1.3.1 Global Cold Agglutinin Disease Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Specialty Clinics 1.3.4 Homecare 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cold Agglutinin Disease Market Perspective (2017-2028) 2.2 Cold Agglutinin Disease Growth Trends by Region 2.2.1 Cold Agglutinin Disease Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Cold Agglutinin Disease Historic Market Size by Region (2017-2022) 2.2.3 Cold Agglutinin Disease Forecasted Market Size by Region (2023-2028) 2.3 Cold Agglutinin Disease Market Dynamics 2.3.1 Cold Agglutinin Disease Industry Trends 2.3.2 Cold Agglutinin Disease Market Drivers 2.3.3 Cold Agglutinin Disease Market Challenges 2.3.4 Cold Agglutinin Disease Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cold Agglutinin Disease Players by Revenue 3.1.1 Global Top Cold Agglutinin Disease Players by Revenue (2017-2022) 3.1.2 Global Cold Agglutinin Disease Revenue Market Share by Players (2017-2022) 3.2 Global Cold Agglutinin Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Cold Agglutinin Disease Revenue 3.4 Global Cold Agglutinin Disease Market Concentration Ratio 3.4.1 Global Cold Agglutinin Disease Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cold Agglutinin Disease Revenue in 2021 3.5 Cold Agglutinin Disease Key Players Head office and Area Served 3.6 Key Players Cold Agglutinin Disease Product Solution and Service 3.7 Date of Enter into Cold Agglutinin Disease Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cold Agglutinin Disease Breakdown Data by Type 4.1 Global Cold Agglutinin Disease Historic Market Size by Type (2017-2022) 4.2 Global Cold Agglutinin Disease Forecasted Market Size by Type (2023-2028) 5 Cold Agglutinin Disease Breakdown Data by Application 5.1 Global Cold Agglutinin Disease Historic Market Size by Application (2017-2022) 5.2 Global Cold Agglutinin Disease Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Cold Agglutinin Disease Market Size (2017-2028) 6.2 North America Cold Agglutinin Disease Market Size by Country (2017-2022) 6.3 North America Cold Agglutinin Disease Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Cold Agglutinin Disease Market Size (2017-2028) 7.2 Europe Cold Agglutinin Disease Market Size by Country (2017-2022) 7.3 Europe Cold Agglutinin Disease Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Cold Agglutinin Disease Market Size (2017-2028) 8.2 Asia-Pacific Cold Agglutinin Disease Market Size by Country (2017-2022) 8.3 Asia-Pacific Cold Agglutinin Disease Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Cold Agglutinin Disease Market Size (2017-2028) 9.2 Latin America Cold Agglutinin Disease Market Size by Country (2017-2022) 9.3 Latin America Cold Agglutinin Disease Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cold Agglutinin Disease Market Size (2017-2028) 10.2 Middle East & Africa Cold Agglutinin Disease Market Size by Country (2017-2022) 10.3 Middle East & Africa Cold Agglutinin Disease Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Detail 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Cold Agglutinin Disease Introduction 11.1.4 Sanofi Revenue in Cold Agglutinin Disease Business (2017-2022) 11.1.5 Sanofi Recent Development 11.2 Pfizer Inc. 11.2.1 Pfizer Inc. Company Detail 11.2.2 Pfizer Inc. Business Overview 11.2.3 Pfizer Inc. Cold Agglutinin Disease Introduction 11.2.4 Pfizer Inc. Revenue in Cold Agglutinin Disease Business (2017-2022) 11.2.5 Pfizer Inc. Recent Development 11.3 GlaxoSmithKline plc 11.3.1 GlaxoSmithKline plc Company Detail 11.3.2 GlaxoSmithKline plc Business Overview 11.3.3 GlaxoSmithKline plc Cold Agglutinin Disease Introduction 11.3.4 GlaxoSmithKline plc Revenue in Cold Agglutinin Disease Business (2017-2022) 11.3.5 GlaxoSmithKline plc Recent Development 11.4 Novartis AG 11.4.1 Novartis AG Company Detail 11.4.2 Novartis AG Business Overview 11.4.3 Novartis AG Cold Agglutinin Disease Introduction 11.4.4 Novartis AG Revenue in Cold Agglutinin Disease Business (2017-2022) 11.4.5 Novartis AG Recent Development 11.5 Zydus Cadila 11.5.1 Zydus Cadila Company Detail 11.5.2 Zydus Cadila Business Overview 11.5.3 Zydus Cadila Cold Agglutinin Disease Introduction 11.5.4 Zydus Cadila Revenue in Cold Agglutinin Disease Business (2017-2022) 11.5.5 Zydus Cadila Recent Development 11.6 AstraZeneca 11.6.1 AstraZeneca Company Detail 11.6.2 AstraZeneca Business Overview 11.6.3 AstraZeneca Cold Agglutinin Disease Introduction 11.6.4 AstraZeneca Revenue in Cold Agglutinin Disease Business (2017-2022) 11.6.5 AstraZeneca Recent Development 11.7 Johnson & Johnson 11.7.1 Johnson & Johnson Company Detail 11.7.2 Johnson & Johnson Business Overview 11.7.3 Johnson & Johnson Cold Agglutinin Disease Introduction 11.7.4 Johnson & Johnson Revenue in Cold Agglutinin Disease Business (2017-2022) 11.7.5 Johnson & Johnson Recent Development 11.8 Bayer AG 11.8.1 Bayer AG Company Detail 11.8.2 Bayer AG Business Overview 11.8.3 Bayer AG Cold Agglutinin Disease Introduction 11.8.4 Bayer AG Revenue in Cold Agglutinin Disease Business (2017-2022) 11.8.5 Bayer AG Recent Development 11.9 Sun Pharmaceutical Industries Ltd. 11.9.1 Sun Pharmaceutical Industries Ltd. Company Detail 11.9.2 Sun Pharmaceutical Industries Ltd. Business Overview 11.9.3 Sun Pharmaceutical Industries Ltd. Cold Agglutinin Disease Introduction 11.9.4 Sun Pharmaceutical Industries Ltd. Revenue in Cold Agglutinin Disease Business (2017-2022) 11.9.5 Sun Pharmaceutical Industries Ltd. Recent Development 11.10 Apellis Pharmaceuticals 11.10.1 Apellis Pharmaceuticals Company Detail 11.10.2 Apellis Pharmaceuticals Business Overview 11.10.3 Apellis Pharmaceuticals Cold Agglutinin Disease Introduction 11.10.4 Apellis Pharmaceuticals Revenue in Cold Agglutinin Disease Business (2017-2022) 11.10.5 Apellis Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cold Agglutinin Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Corticosteroids Table 3. Key Players of Alkylating Agents Table 4. Key Players of Purine Nucleoside Analogs Table 5. Key Players of Biologics Table 6. Key Players of Others Table 7. Global Cold Agglutinin Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Cold Agglutinin Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Cold Agglutinin Disease Market Size by Region (2017-2022) & (US$ Million) Table 10. Global Cold Agglutinin Disease Market Share by Region (2017-2022) Table 11. Global Cold Agglutinin Disease Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 12. Global Cold Agglutinin Disease Market Share by Region (2023-2028) Table 13. Cold Agglutinin Disease Market Trends Table 14. Cold Agglutinin Disease Market Drivers Table 15. Cold Agglutinin Disease Market Challenges Table 16. Cold Agglutinin Disease Market Restraints Table 17. Global Cold Agglutinin Disease Revenue by Players (2017-2022) & (US$ Million) Table 18. Global Cold Agglutinin Disease Market Share by Players (2017-2022) Table 19. Global Top Cold Agglutinin Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Agglutinin Disease as of 2021) Table 20. Ranking of Global Top Cold Agglutinin Disease Companies by Revenue (US$ Million) in 2021 Table 21. Global 5 Largest Players Market Share by Cold Agglutinin Disease Revenue (CR5 and HHI) & (2017-2022) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Cold Agglutinin Disease Product Solution and Service Table 24. Date of Enter into Cold Agglutinin Disease Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Cold Agglutinin Disease Market Size by Type (2017-2022) & (US$ Million) Table 27. Global Cold Agglutinin Disease Revenue Market Share by Type (2017-2022) Table 28. Global Cold Agglutinin Disease Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 29. Global Cold Agglutinin Disease Revenue Market Share by Type (2023-2028) Table 30. Global Cold Agglutinin Disease Market Size by Application (2017-2022) & (US$ Million) Table 31. Global Cold Agglutinin Disease Revenue Market Share by Application (2017-2022) Table 32. Global Cold Agglutinin Disease Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 33. Global Cold Agglutinin Disease Revenue Market Share by Application (2023-2028) Table 34. North America Cold Agglutinin Disease Market Size by Country (2017-2022) & (US$ Million) Table 35. North America Cold Agglutinin Disease Market Size by Country (2023-2028) & (US$ Million) Table 36. Europe Cold Agglutinin Disease Market Size by Country (2017-2022) & (US$ Million) Table 37. Europe Cold Agglutinin Disease Market Size by Country (2023-2028) & (US$ Million) Table 38. Asia-Pacific Cold Agglutinin Disease Market Size by Region (2017-2022) & (US$ Million) Table 39. Asia-Pacific Cold Agglutinin Disease Market Size by Region (2023-2028) & (US$ Million) Table 40. Latin America Cold Agglutinin Disease Market Size by Country (2017-2022) & (US$ Million) Table 41. Latin America Cold Agglutinin Disease Market Size by Country (2023-2028) & (US$ Million) Table 42. Middle East & Africa Cold Agglutinin Disease Market Size by Country (2017-2022) & (US$ Million) Table 43. Middle East & Africa Cold Agglutinin Disease Market Size by Country (2023-2028) & (US$ Million) Table 44. Sanofi Company Detail Table 45. Sanofi Business Overview Table 46. Sanofi Cold Agglutinin Disease Product Table 47. Sanofi Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 48. Sanofi Recent Development Table 49. Pfizer Inc. Company Detail Table 50. Pfizer Inc. Business Overview Table 51. Pfizer Inc. Cold Agglutinin Disease Product Table 52. Pfizer Inc. Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 53. Pfizer Inc. Recent Development Table 54. GlaxoSmithKline plc Company Detail Table 55. GlaxoSmithKline plc Business Overview Table 56. GlaxoSmithKline plc Cold Agglutinin Disease Product Table 57. GlaxoSmithKline plc Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 58. GlaxoSmithKline plc Recent Development Table 59. Novartis AG Company Detail Table 60. Novartis AG Business Overview Table 61. Novartis AG Cold Agglutinin Disease Product Table 62. Novartis AG Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 63. Novartis AG Recent Development Table 64. Zydus Cadila Company Detail Table 65. Zydus Cadila Business Overview Table 66. Zydus Cadila Cold Agglutinin Disease Product Table 67. Zydus Cadila Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 68. Zydus Cadila Recent Development Table 69. AstraZeneca Company Detail Table 70. AstraZeneca Business Overview Table 71. AstraZeneca Cold Agglutinin Disease Product Table 72. AstraZeneca Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 73. AstraZeneca Recent Development Table 74. Johnson & Johnson Company Detail Table 75. Johnson & Johnson Business Overview Table 76. Johnson & Johnson Cold Agglutinin Disease Product Table 77. Johnson & Johnson Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 78. Johnson & Johnson Recent Development Table 79. Bayer AG Company Detail Table 80. Bayer AG Business Overview Table 81. Bayer AG Cold Agglutinin Disease Product Table 82. Bayer AG Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 83. Bayer AG Recent Development Table 84. Sun Pharmaceutical Industries Ltd. Company Detail Table 85. Sun Pharmaceutical Industries Ltd. Business Overview Table 86. Sun Pharmaceutical Industries Ltd. Cold Agglutinin Disease Product Table 87. Sun Pharmaceutical Industries Ltd. Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 88. Sun Pharmaceutical Industries Ltd. Recent Development Table 89. Apellis Pharmaceuticals Company Detail Table 90. Apellis Pharmaceuticals Business Overview Table 91. Apellis Pharmaceuticals Cold Agglutinin Disease Product Table 92. Apellis Pharmaceuticals Revenue in Cold Agglutinin Disease Business (2017-2022) & (US$ Million) Table 93. Apellis Pharmaceuticals Recent Development Table 94. Research Programs/Design for This Report Table 95. Key Data Information from Secondary Sources Table 96. Key Data Information from Primary Sources List of Figures Figure 1. Global Cold Agglutinin Disease Market Share by Type: 2021 VS 2028 Figure 2. Corticosteroids Features Figure 3. Alkylating Agents Features Figure 4. Purine Nucleoside Analogs Features Figure 5. Biologics Features Figure 6. Others Features Figure 7. Global Cold Agglutinin Disease Market Share by Application in 2021 & 2028 Figure 8. Hospitals Case Studies Figure 9. Specialty Clinics Case Studies Figure 10. Homecare Case Studies Figure 11. Others Case Studies Figure 12. Cold Agglutinin Disease Report Years Considered Figure 13. Global Cold Agglutinin Disease Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 14. Global Cold Agglutinin Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 15. Global Cold Agglutinin Disease Market Share by Region: 2021 VS 2028 Figure 16. Global Cold Agglutinin Disease Market Share by Players in 2021 Figure 17. Global Top Cold Agglutinin Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Agglutinin Disease as of 2021) Figure 18. The Top 10 and 5 Players Market Share by Cold Agglutinin Disease Revenue in 2021 Figure 19. North America Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. North America Cold Agglutinin Disease Market Share by Country (2017-2028) Figure 21. United States Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Europe Cold Agglutinin Disease Market Share by Country (2017-2028) Figure 25. Germany Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. France Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. U.K. Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Italy Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Russia Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Nordic Countries Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Asia-Pacific Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Cold Agglutinin Disease Market Share by Region (2017-2028) Figure 33. China Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Japan Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. South Korea Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Southeast Asia Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. India Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Australia Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Latin America Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Latin America Cold Agglutinin Disease Market Share by Country (2017-2028) Figure 41. Mexico Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Brazil Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Middle East & Africa Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Middle East & Africa Cold Agglutinin Disease Market Share by Country (2017-2028) Figure 45. Turkey Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Saudi Arabia Cold Agglutinin Disease Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Sanofi Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 48. Pfizer Inc. Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 49. GlaxoSmithKline plc Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 50. Novartis AG Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 51. Zydus Cadila Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 52. AstraZeneca Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 53. Johnson & Johnson Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 54. Bayer AG Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 55. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 56. Apellis Pharmaceuticals Revenue Growth Rate in Cold Agglutinin Disease Business (2017-2022) Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Sanofi Pfizer Inc. GlaxoSmithKline plc Novartis AG Zydus Cadila AstraZeneca Johnson & Johnson Bayer AG Sun Pharmaceutical Industries Ltd. Apellis Pharmaceuticals